These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15182810)

  • 1. Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases.
    Smith PA; Sorich MJ; Low LS; McKinnon RA; Miners JO
    J Mol Graph Model; 2004 Jul; 22(6):507-17. PubMed ID: 15182810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the metabolism rate of quinone analogues from molecular dynamics simulation and 3D-QSMR methods.
    Chen HF; Wu MY; Wang Z; Wei DQ
    Chem Biol Drug Des; 2007 Oct; 70(4):290-301. PubMed ID: 17937775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting ADME properties and side effects: the BioPrint approach.
    Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid prediction of chemical metabolism by human UDP-glucuronosyltransferase isoforms using quantum chemical descriptors derived with the electronegativity equalization method.
    Sorich MJ; McKinnon RA; Miners JO; Winkler DA; Smith PA
    J Med Chem; 2004 Oct; 47(21):5311-7. PubMed ID: 15456275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico insights: chemical and structural characteristics associated with uridine diphosphate-glucuronosyltransferase substrate selectivity.
    Smith PA; Sorich MJ; McKinnon RA; Miners JO
    Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):836-40. PubMed ID: 14678246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure activity relationships in drug metabolism.
    Chohan KK; Paine SW; Waters NJ
    Curr Top Med Chem; 2006; 6(15):1569-78. PubMed ID: 16918469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoforms.
    Sorich MJ; Miners JO; McKinnon RA; Winkler DA; Burden FR; Smith PA
    J Chem Inf Comput Sci; 2003; 43(6):2019-24. PubMed ID: 14632453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico log P prediction for a large data set with support vector machines, radial basis neural networks and multiple linear regression.
    Chen HF
    Chem Biol Drug Des; 2009 Aug; 74(2):142-7. PubMed ID: 19549084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions.
    Zernov VV; Balakin KV; Ivaschenko AA; Savchuk NP; Pletnev IV
    J Chem Inf Comput Sci; 2003; 43(6):2048-56. PubMed ID: 14632457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
    Miners JO; Knights KM; Houston JB; Mackenzie PI
    Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method.
    Narayanan R; Gunturi SB
    Bioorg Med Chem; 2005 Apr; 13(8):3017-28. PubMed ID: 15781411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.
    Siraki AG; Chevaldina T; Moridani MY; O'Brien PJ
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):118-25. PubMed ID: 14982155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches.
    Miners JO; Smith PA; Sorich MJ; McKinnon RA; Mackenzie PI
    Annu Rev Pharmacol Toxicol; 2004; 44():1-25. PubMed ID: 14744236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined approach to drug metabolism and toxicity assessment.
    Ekins S; Andreyev S; Ryabov A; Kirillov E; Rakhmatulin EA; Sorokina S; Bugrim A; Nikolskaya T
    Drug Metab Dispos; 2006 Mar; 34(3):495-503. PubMed ID: 16381662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.